FCGR2B and systemic lupus erythematosus: Fcgr2b-deficient mice have shown elevated type I IFN signaling, leading to increased autoantibody production and SLE-like symptoms in mice by 6–8 months in the 129/Sv B6 background but not in the BALB/C background9,11.